Counselors in Phoenix, MD Accepting Medicare
7 Counselors found. Showing 1 - 7
 Amy Ruth Rakusin, LCPC, ADTR, NCC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 10 Cross Creek Ct, Phoenix, MD 21131 Phone: 410-472-3060 Fax: 410-472-9958 |
Mrs. Joan Mesmeringer Jurkowski, LCPC Counselor Medicare: Medicare Enrolled Practice Location: 3313 Paper Mill Rd, Suite 5, Phoenix, MD 21131 Phone: 410-790-9604 |
Christine Lanzi, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 3313 Paper Mill Rd Ste 5, Phoenix, MD 21131 Phone: 443-845-2910 |
Nadia Maghsadi, LCPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 12894 Eagles View Rd, Phoenix, MD 21131 Phone: 443-465-9262 |
Dr. Sharon Aletta Thomas-parker, LCPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2820 Paper Mill Rd, Phoenix, MD 21131 Phone: 410-365-1010 Fax: 410-584-7969 |
Mrs. Cynthia Dewaters Balog, LCPC LCADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3314 Paper Mill Rd Ste 100, Phoenix, MD 21131 Phone: 410-802-4049 Fax: 866-561-6670 |
Dr. Carol Zoanne Mcginnis, PHD, LCPC Counselor - Pastoral Medicare: Not Enrolled in Medicare Practice Location: 13916 Jarrettsville Pike, Phoenix, MD 21131 Phone: 410-666-8288 |
News Archive
Partial dentin removal superior to stepwise excavation over long term
Partial caries removal treatment for individuals with deep caries lesions results in significantly improved pulp vitality after 3 years than does stepwise excavation, indicate Brazilian study findings.
MAXIMUS signs new contract with Colorado Department of Health Care Policy and Financing
MAXIMUS announced today that it has signed a new contract with the Colorado Department of Health Care Policy and Financing to help Colorado modernize eligibility and enrollment for its Medical Assistance programs, including Medicaid and the Children's Health Insurance Program.
CoPlex, Hawthorn sign license agreement for hawAD14 Alzheimer's drug
CoPlex Therapeutics has signed an exclusive global license agreement with Hawthorn Pharmaceuticals to develop and commercialize hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other neurodegenerative diseases.
New technology rapidly detects tumor response to chemotherapy
New technology developed by Duke University bioengineers can help clinicians more precisely detect whether specific cancer drugs are working, and should give basic researchers a powerful new tool to better understand the underlying mechanisms of cancer development.
New approach could help identify specific gene mutations linked to increased disease risk
Researchers at the University of California, San Diego School of Medicine have developed a new way to parse and understand how special proteins called "master regulators" read the genome, and consequently turn genes on and off.
› Verified 3 days ago
Pharmacists
Counselors
Clinical Social Workers
Occupational Therapists
Psychologists
Dentists